This high co-occurrence can be attributed to the discovery ofPD-1/PD-L1 inhibitors as effective treatment for NSCLC.69 Cytotoxic T-lymphocyte-associated antigen 4(CTLA-4) shows a slightly higher degree of overlap with lung canceras compared to other solid tumors. This evidence concerns the gene CTLA4 and non-small cell lung carcinoma.